Share on StockTwits

Mallinckrodt PLC (NYSE:MNK) Director Joseph A. Zaccagnino bought 3,000 shares of Mallinckrodt PLC stock in a transaction dated Tuesday, August 19th. The shares were purchased at an average cost of $71.06 per share, with a total value of $213,180.00. Following the purchase, the director now directly owns 9,774 shares of the company’s stock, valued at approximately $694,540. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

A number of analysts have recently weighed in on MNK shares. Analysts at Leerink Swann cut their price target on shares of Mallinckrodt PLC from $90.00 to $77.00 in a research note on Friday, August 8th. Separately, analysts at Keefe, Bruyette & Woods reiterated a “market perform” rating on shares of Mallinckrodt PLC in a research note on Friday, August 8th. They now have a $77.00 price target on the stock, down previously from $90.00. Finally, analysts at Bank of America raised their price target on shares of Mallinckrodt PLC to $97.00 in a research note on Tuesday, July 29th. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Mallinckrodt PLC has a consensus rating of “Buy” and a consensus target price of $85.78.

Mallinckrodt PLC (NYSE:MNK) traded up 0.03% on Thursday, hitting $72.19. The stock had a trading volume of 483,937 shares. Mallinckrodt PLC has a 52 week low of $41.67 and a 52 week high of $83.20. The stock has a 50-day moving average of $73.33 and a 200-day moving average of $70.98. The company has a market cap of $4.228 billion and a price-to-earnings ratio of 63.81.

Mallinckrodt PLC (NYSE:MNK) last released its earnings data on Thursday, August 7th. The company reported $1.20 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.87 by $0.33. The company had revenue of $653.10 million for the quarter, compared to the consensus estimate of $278.80 million. During the same quarter last year, the company posted $0.49 earnings per share. Mallinckrodt PLC’s revenue was up 14.6% compared to the same quarter last year. Analysts expect that Mallinckrodt PLC will post $4.42 EPS for the current fiscal year.

Mallinckrodt public limited company (NYSE:MNK) is a global specialty pharmaceuticals company.

Receive News & Ratings for Mallinckrodt PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mallinckrodt PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.